How Much for an Antibiotic that Could Help Hillary? Cempra Tests Fair Price

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $149 per year, you reward quality independent biotech reporting, and encourage more.

You may also like

Can Biotech and Pharma Be Restrained in an Unrestrained World?
Q&A on Drug Pricing with Gilead’s Gregg Alton: Outtakes From the Podcast
‘Quit Whining’ and 11 Other Ways Industry Should Communicate Better
A Timeline of the Turing Pharma Controversy